Polynucleotides encoding hOCTN1 polypeptide

Details Polynucleotides encoding hOCTN1 polypeptide Polynucleotides encoding hOCTN1 polypeptide

2011-05-24

2011-05-24

Bunner, Bridget E (Department: 1647)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

C435S070100, C435S252300, C435S320100, C435S325000, C530S350000, C536S023500

Reexamination Certificate

active

07947470

ABSTRACT:
Novel genes significantly homologous to organic cation transporters OCT1 and OCT2 have been successfully isolated by screening a fetal gene library by random sequencing. Proteins encoded by these genes function as transporters of various organic cations.

REFERENCES:
patent: 6063623 (2000-05-01), Koepsell et al.
patent: 6759514 (2004-07-01), Nezu et al.
patent: 6790831 (2004-09-01), Nezu et al.
patent: 7413860 (2008-08-01), Nezu et al.
patent: 2009/0220967 (2009-09-01), Nezu et al.
patent: 0 699 753 (1996-03-01), None
patent: 8-81497 (1996-03-01), None
patent: 10-146188 (1998-06-01), None
patent: WO 97/42321 (1997-11-01), None
patent: WO 99/13072 (1999-03-01), None
patent: WO 00/14210 (2000-03-01), None
Skolnick et al. From genes to protein structure and function: novel applications of computational approaches in the genomic era. Trends in Biotech 18(1): 34-39, 2000.
Bork, A. Powers and pitfalls in sequence analysis: the 70% hurdle. Genome Res 10: 398-400, 2000.
Doerks et al. Protein annotation: detective work for function prediction. Trends in Genetics 14(6): 248-250, 1998.
Smith et al. The challenges of genome sequence annotation or “The devil is in the details”. Nature Biotech 15: 1222-1223, 1997.
Brenner, S.E. Errors in genome function. Trends in Genetics 15(4): 132-133, 1999.
Bork et al. Go hunting in sequence databases but watch out for the traps. Trends in Genetics. 12(10): 425-427, 1996.
Wells. J.A. Additivity of mutational effects in proteins. Biochemistry 29 (37): 8509-8517, 1990.
Ngo et al. Computational complexity, protein structure prediction, and the Levinthal paradox. The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495, 1994.
Barrett et al. Structure and function of facilitative sugar transporters. Curr Opin Cell Biol. 11(4):496-502, 1999.
Bisson et al. Yeast sugar transporters. Crit Rev Biochem Molec Biol 28(4): 259-308, 1993.
Liang et al. Trinucleotide insertions, deletions, and point mutations in glucose transporters confer K+ uptake inSaccharomyces cerevisiae. Mol Cell Biol. 18(2):926-935, 1998.
Koepsell et al. The SLC22 drug transporter family. Pflugers Arch-Eur J Physiol 447: 666-676, 2004.
Koepsell et al. Organic cation transporters. Rev Physiol Biochem Pharmacol 150: 36-90, 2003.
Tamai et al. Genbank Accession No. AB007448, Feb. 13, 1999.
Martin et al. Genbank Accession No. HSL81760, Apr. 9, 1997.
Wang et al., “Mutations in the . . . ,” Proc. Natl. Acad. Sci. USA, 96:2356-2360, 1999.
Wu et al., “cDNA Sequence . . . ,” Biochemical and Biophysical Research Communications, 246:589-595, 1998.
Yabuuchi et al., “Novel Membrane . . . ,” The Journal of Pharmacology and Experimental Therapeutics, 289(2):768-773, 1999.
Tamai et al., “Molecular and Functional . . . ,” The Journal of Biological Chemistry, 273(32):20378-20382, 1998.
Nezu et al., “Primary systemic . . . ,” Nature Genetics, 21:91-94, 1999.
Tamai et al., “Cloning and characterization . . . ,” FEBS Letter, 419:107-111, 1997.
English Translation of WO 00/14210 A1.
Grundemann D. et al., “Drug excretion mediated by a new prototype . . . ”, Nature, 1994, 372(6506);549-52.
Okuda M. et al., “cDNA Cloning and Functional Expression of a Novel Rat . . . ”, Biochem Biophys Res Commun, 1996, 224(2);500-7.
Gorboulev et al., “Cloning and characterization of two human polyspecific . . . ”, 1997,DNA and Cell Biology, vol. 16(7);871-881.
Schweifer et al., “The L-chi-1 gene maps to mouse . . . ”, 1996,Mammalian Genome, vol. 7(10);735-740.
Chun et al., “Expression of human polyspecific renal organic . . . ”, 1997,J. Pharmaceutical Sciences, vol. 86(6);753-755.
Lopez-nieto et al., “Molecular cloning and characterization of NKT . . . ”, 1997,J. Biolog. Chem., vol. 272(10);6471-6478.
GenBank Accession No. AA428395, May 25, 1997.
GenBank Accession No. AA024584, Aug. 14, 1996.
GenBank Accession No. AA189399, Jan. 20, 1997.
Simonson et al., “Molecular cloning and characterization of a novel . . . ”, 1994,J. Cell Science, vol. 107(4);1065-1072.
Gruendemann et al., “Primary structure and functional expression of the apical organic . . . ”, 1997,J. Biol. Chem., vol. 272(16);10408-10413.
Zhang et al., “Cloning and functional expression of a human liver . . . ”, 1997,Molecular Pharmacology, vol. 51(6);913-921.
European Search Report for Application No. 98941751.4-2403-JP9804009, mailed Sep. 16, 2002.
Mikajama et al., Proc. Natl. Acad. Sci. USA 1993 vol. 90;10056-10060.
Voct et al., Biochemisrty, John Wiley and Sons Inc., 1990;126-128 and 228-234.
Bowie et al. “Deciphering the message in protein sequences: Tolerance to amino acid substitutions”Science, vol. 247: pp. 1306-1310 (1990).
Lamhonwah et al., “Camitine Uptake Defect: Frameshift Mutations in the Human Plasmalemmal Camitine Transporter Gene,”Biochem. Biophys. Res. Commun., 252:396-401 (1998).
Lu et al., “A Missense Mutation of Mouse OCTN2, a Sodium-Dependent Carnitine Cotransporter, in the Juvenile Visceral Steatosis Mouse,”Biochem. Biophys. Res. Commun., 252:590-594 (1998).
Masuda et al., “A novel gene suppressed in the ventricle of carnitine-deficient juvenile visceral steatosis mice,”FEBS Lett., 408:221-224 (1997).
Nezu et al., “A Step Forward in Elucidating the Mechanism of Fatty Acid Metabolism: Discovery of OCTN2 Gene Responsible for Systemic Carnitine Deficiency, and Significance Thereof,”Medikaru Asahi(Asahi Monthly J. of Medicine), 28:26-29 (1999) (English translation attached).
Okita et al., “Definition of the Locus Responsible for Systemic Carnitine Deficiency within a 1.6-cM Region of Mouse Chromosome 11 by Detailed Linkage Analysis,”Genomics, 33:289-291 (1996).
Shoji et al., “Evidence for Linkage of Human Primary Systemic Carnitine Deficiency with D5S436: a Novel Gene Locus on Chromosome 5q,”Am. J. Hum. Genet6., 63:101-108 (1998).
Tein et al., “Impaired Skin Fibroblast Carnitine Uptake in Primary Systemic Camitine Deficiency Manifested by Childhood Carnitine-Responsive Cardiomyopathy,”Pediatr. Res., 28:247-255 (1990).
Tsuji, “Membrane Transport of Carnitine, a Major Factor on Fatty Acid Metabolism, and Its Deficiency Syndromes,”Saibo Kogaku(Cell Technology), 18:1698-1706 (1999) (English abstract attached).
Dubuisson et al., “Ontogenic expression of the Na+-independent organic anion transporting polypeptide (oatp) in rat liver and kidney,”J. Hepatol., 25:932-940 (1996).
Izquierdo et al., “Changing Patterns of Transcriptional and Post-transcriptional Control of β-F1-ATPase Gene Expression during Mitochondrial Biogenesis in Liver,”J. Biol. Chem., 270:10342-10350 (1995).
Schömig et al., “Molecular cloning and characterization of two novel transport proteins from rat kidney,”FEBS Lett., 425:79-86 (1998).
Bowie et al. “Deciphering the message in protein sequences: Tolerance to amino acid substitutions” Science, 247:1306-1310 (1990).
Maiden et al., “Mammalian and Bacterial Sugar Transport Proteins are Homologous,” Nature, 18(325):641-643 (1987).
Meijer et al., “Carrier-Mediated Transport in Hepatic Distribution and Elimination of Drugs with Special Reference to the Category of Organic Cations,” J. Pharmacokinetics and Biopharmaceuticals, 18(1):35-70 (1990).
Tsuji et al., “Carrier-Mediated Intestinal Transport of Drugs,” Pharmaceutical Research, 13(7): 963-977 (1996).
Ullrich et al., “Renal Transport Mechanisms for Xenobiotics: Chemicals and Drugs,” Clin. Investg, 71:843-848 (1993).
USPTO Restriction Requirement in U.S. Appl. No. 09/521,195, mailed Jun. 22, 2001 (6 pages).
Fish & Richardson P.C., Response to Restriction Requirement dated Jun. 22, 2001 in U.S. Appl. No. 09/521,195, filed Jul. 23, 2001 (5 pages).
USPTO Restriction Requirement in U.S. Appl. No. 09/521,195, mailed Feb

Affiliated with

Also associated with

Rating

Polynucleotides encoding hOCTN1 polypeptide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polynucleotides encoding hOCTN1 polypeptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polynucleotides encoding hOCTN1 polypeptide will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2672135